301 related articles for article (PubMed ID: 26297381)
1. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the retinal nerve fiber and ganglion cell - Inner plexiform layer by optical coherence tomography in Parkinson's patients.
Ucak T; Alagoz A; Cakir B; Celik E; Bozkurt E; Alagoz G
Parkinsonism Relat Disord; 2016 Oct; 31():59-64. PubMed ID: 27423922
[TBL] [Abstract][Full Text] [Related]
3. Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J
Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320
[TBL] [Abstract][Full Text] [Related]
4. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease.
Stemplewitz B; Keserü M; Bittersohl D; Buhmann C; Skevas C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Dec; 93(8):e672-7. PubMed ID: 26066643
[TBL] [Abstract][Full Text] [Related]
5. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.
Yang ZJ; Wei J; Mao CJ; Zhang JR; Chen J; Ji XY; Liu JY; Shen Y; Xiong KP; Huang JY; Yang YP; Liu CF
Sleep Breath; 2016 Dec; 20(4):1285-1292. PubMed ID: 27259748
[TBL] [Abstract][Full Text] [Related]
6. Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
Bittersohl D; Stemplewitz B; Keserü M; Buhmann C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Nov; 93(7):e578-84. PubMed ID: 26267660
[TBL] [Abstract][Full Text] [Related]
7. Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
[TBL] [Abstract][Full Text] [Related]
8. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C
Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112
[TBL] [Abstract][Full Text] [Related]
9. Progressive Changes in the Retinal Structure of Patients with Parkinson's Disease.
Ma LJ; Xu LL; Mao CJ; Fu YT; Ji XY; Shen Y; Chen J; Yang YP; Liu CF
J Parkinsons Dis; 2018; 8(1):85-92. PubMed ID: 29480221
[TBL] [Abstract][Full Text] [Related]
10. [A clinical study of changes in retina and visual field in patients with early Parkinson's disease].
Li L; Ji X; Mao C; Chen Y; Guo S; Li S; Liu C
Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):521-4. PubMed ID: 26359014
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between Structural and Functional Retinal Changes in Parkinson Disease.
Kaur M; Saxena R; Singh D; Behari M; Sharma P; Menon V
J Neuroophthalmol; 2015 Sep; 35(3):254-8. PubMed ID: 25807477
[TBL] [Abstract][Full Text] [Related]
12. Retinal pathology detected by optical coherence tomography in an animal model of Parkinson's disease.
Schneider JS; Ault ME; Anderson DW
Mov Disord; 2014 Oct; 29(12):1547-51. PubMed ID: 25070726
[TBL] [Abstract][Full Text] [Related]
13. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.
Sari ES; Koc R; Yazici A; Sahin G; Ermis SS
J Neuroophthalmol; 2015 Jun; 35(2):117-21. PubMed ID: 25485861
[TBL] [Abstract][Full Text] [Related]
14. Characterization of retinal architecture in Parkinson's disease.
Chorostecki J; Seraji-Bozorgzad N; Shah A; Bao F; Bao G; George E; Gorden V; Caon C; Frohman E; Bhatti MT; Khan O
J Neurol Sci; 2015 Aug; 355(1-2):44-8. PubMed ID: 26071887
[TBL] [Abstract][Full Text] [Related]
15. In vivo exploration of retinal nerve fiber layer morphology in Parkinson's disease patients.
Visser F; Vermeer KA; Ghafaryasl B; Vlaar AMM; Apostolov V; van Hellenberg Hubar J; Weinstein HC; de Boer JF; Berendse HW
J Neural Transm (Vienna); 2018 Jun; 125(6):931-936. PubMed ID: 29520613
[TBL] [Abstract][Full Text] [Related]
16. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Adam CR; Shrier E; Ding Y; Glazman S; Bodis-Wollner I
J Neuroophthalmol; 2013 Jun; 33(2):137-42. PubMed ID: 23612240
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of related parameters of retinal nerve fiber layer and ganglion cell complex thickness in patients with different degrees of Parkinson's disease.
Zhao Y; Dai W; Liu D
Aging Clin Exp Res; 2022 Oct; 34(10):2355-2361. PubMed ID: 36048412
[TBL] [Abstract][Full Text] [Related]
18. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
[TBL] [Abstract][Full Text] [Related]
19. Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.
Winges KM; Werner JS; Harvey DJ; Cello KE; Durbin MK; Balcer LJ; Calabresi PA; Keltner JL
J Neuroophthalmol; 2013 Dec; 33(4):322-9. PubMed ID: 24051419
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of peripapillary retinal nerve fiber layer thickness in patients with vitamin B12 deficiency using spectral domain optical coherence tomography.
Türkyılmaz K; Öner V; Türkyılmaz AK; Kırbaş A; Kırbaş S; Şekeryapan B
Curr Eye Res; 2013 Jun; 38(6):680-4. PubMed ID: 23317171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
